This template supports achievement of multiple QOF diabetes indicators, including:
DM020/DM021 โ HbA1c control
DM034/DM035 โ Statin prescribing
DM036 โ Blood pressure control
It also supports additional local enhanced services (LES) and ensures correct frailty stratification, which affects KPI thresholds. Accurate use maximises income while ensuring care is tailored to patient needs.
Indicator thresholds differ based on frailty status:
HbA1c target: โค58 mmol/mol
BP target (if aged <80): โค140/90 (or โค135/85 if home/ambulatory)
Statin required if over 40 without CVD (unless 10-year QRISK <10%)
HbA1c target: โค75 mmol/mol
No BP or statin indicators apply unless the patient has CVD (in which case statin still applies)
This template covers all key components:
Based on the Rockwood Clinical Frailty Scale
Required to determine which QOF targets apply
Options: Not frail, Moderately frail, Severely frail
Enter clinic, home, or ambulatory readings
Tick if patient is exempt due to clinical judgement or maximal tolerated treatment
Automatically interprets HbA1c target based on frailty
Tick exception if:
On maximal tolerated treatment
Patient refuses blood tests
Required for:
All with CVD
Those aged 40+ without CVD/frailty, unless QRISK <10%
If statin not appropriate:
Tick if declined
Tick if clinically unsuitable
Record alternative lipid-lowering therapy (e.g. ezetimibe, inclisiran)
Frailty status drives indicator thresholds โ always complete this first.
Use home/ambulatory BP if clinic reading fails to meet target.
If HbA1c is not at target, always explain why using the PCA section.
Patients with CVD must be on a statin regardless of frailty โ unless exception coded.
Remember: PCAs such as "statin not tolerated" may be one-time entries, while others must be renewed annually.